Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway.
Zhang W, Dong J, Xu J, Qian Y, Chen D, Fan Z, Yang H, Xiang J, Xue X, Luo X, Jiang Y, Wang Y, Huang Z.
Zhang W, et al. Among authors: fan z.
Biochem Pharmacol. 2024 May;223:116112. doi: 10.1016/j.bcp.2024.116112. Epub 2024 Mar 6.
Biochem Pharmacol. 2024.
PMID: 38458331